Top Suppliers:I want be here
Related CAS#:

125974-72-3

125974-72-3 structure
125974-72-3 structure
  • Name: Intoplicine
  • Chemical Name: Intoplicine
  • CAS Number: 125974-72-3
  • Molecular Formula: C21H24N4O
  • Molecular Weight: 348.44100
  • Catalog: Research Areas Cancer
  • Create Date: 2018-03-15 08:00:00
  • Modify Date: 2024-01-08 16:33:10
  • Intoplicine is a DNA topoisomerase I and II inhibitor.

Name Intoplicine
Synonyms 11-((3-(Dimethylamino)propyl)amino)-8-methyl-7H-benzo(e)pyrido(4,3-b)indol-3-ol
UNII-FB2CIN6HMI
Description Intoplicine is a DNA topoisomerase I and II inhibitor.
Related Catalog
Target

Topoisomerase I

Topoisomerase II

In Vitro Activity of Intoplicine (RP60475), a new DNA topoisomerase I and II inhibitor, against human tumor colony-forming units in vitro. Intoplicine (RP60475) is the most active analogue evaluated in the 7H-benzo[e]-pyrido-[4,3-b]-indole series of antineoplastic compounds. Intoplicine exerts its activity through inhibition of DNA topoisomerase I and II[1]. Intoplicine is found to unwind DNA and to inhibit purified calf thymus topoisomerase II via a stabilization of the ternary cleavable complex[2].
Kinase Assay The assay is performed with various concentrations of calf thymus Topo II (20 to 0.1 decatenation units) in a 20 μL final reaction volume containing 0.25 μg of supercoiled pBR322 DNA, 20 mM Tris HC1 (pH 7.5), 60 mM KCl, 10 mM MgCl2, 30 μg /mL bovine serum albumin, 0.5 mM EDTA, 0.5 mM Dithiothreitol, and 1 μM Intoplicine or water. The final nucleotide concentration is 20.8 μM.The reaction is assembled in ice and the reaction mixture is then incubated at 37°C for 5 min. Then sample is mixed at room temperature with 20 μL of preaggregated silver hydrosol and immediately analyzed by SERS. Control experiments consisting of measurement of the SERS spectra of buffer alone, Topo II alone, Intoplicine alone (1μM), DNA alone, Topo II+Intoplicine, and DNA+Intoplicine are performed under the same conditions, except that distilled water is used to adjust the reaction volume to 20μL[2].
Cell Assay The K562 human erythroleukemia cell line is established from a patient with chronic myelogenous leukemia. Cells are in the exponential growth phase at 5-8×105 in RPMI 1640 (GIBCO) supplemented with 10% fetal calf serum (Seromed) and 2 mM L-glutamine. Cell growth and viability are determined by phase contrast microscopy and by using the trypan blue test. Cells (2×106) are incubated with 1 μM Intoplicine for 1 h at 37°C, washed twice with PBS by centrifugation (200× g at 4°C) and resuspended in 200 μL PBS[2].
References

[1]. Eckardt JR, et al. Activity of Intoplicine (RP60475), a new DNA topoisomerase I and II inhibitor, against human tumor colony-forming units in vitro. J Natl Cancer Inst. 1994 Jan 5;86(1):30-3.

[2]. Morjani H, et al. Molecular and cellular interactions between Intoplicine, DNA, and topoisomerase II studied by surface-enhanced Raman scattering spectroscopy. Cancer Res. 1993 Oct 15;53(20):4784-90.

Density 1.286g/cm3
Boiling Point 635.5ºC at 760mmHg
Molecular Formula C21H24N4O
Molecular Weight 348.44100
Flash Point 338.2ºC
Exact Mass 348.19500
PSA 64.18000
LogP 4.31990
Vapour Pressure 9.55E-17mmHg at 25°C
Index of Refraction 1.755
Storage condition 2-8℃
Precursor  1

DownStream  0